日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Pimobendan alleviates myocyte apoptosis and fibrosis associated with mitral regurgitation by targeting endoplasmic reticulum stress

匹莫苯丹通过靶向内质网应激，减轻与二尖瓣反流相关的心肌细胞凋亡和纤维化。

期刊:Animal Models and Experimental Medicine
影响因子:3.4
doi:10.1002/ame2.70093
Boonpala, Pakit; Tongta, Sushawadee; Saengklub, Nakkawee; Limprasutr, Vudhiporn; Srikam, Sirinapa; Ji-Au, Wilawan; Boonyarattanasoonthorn, Tussapon; Panyasing, Yaowalak; Kumphune, Sarawut; Kalandakanond-Thongsong, Sarinee; Kijtawornrat, Anusak
细胞生物学
凋亡
表观遗传
内质网应激
发表日期：2025
文献求助 收藏

Pimobendan prevents cardiac dysfunction, mitigates cardiac mitochondrial dysfunction, and preserves myocyte ultrastructure in a rat model of mitral regurgitation

在二尖瓣反流大鼠模型中，匹莫苯丹可预防心脏功能障碍，减轻心脏线粒体功能障碍，并保护心肌细胞超微结构。

期刊:BMC Veterinary Research
影响因子:2.6
doi:10.1186/s12917-023-03693-2
Boonpala, Pakit; Saengklub, Nakkawee; Srikam, Sirinapa; Ji-Au, Wilawan; Panyasing, Yaowalak; Kumphune, Sarawut; Kijtawornrat, Anusak
细胞生物学
线粒体
Rat
发表日期：2023
文献求助 收藏

Thai Osteoporosis Foundation (TOPF) position statements on management of osteoporosis

泰国骨质疏松症基金会（TOPF）关于骨质疏松症管理的立场声明

期刊:
影响因子:
doi:10.1016/j.afos.2016.10.002
Songpatanasilp, T; Sritara, C; Kittisomprayoonkul, W; Chaiumnuay, S; Nimitphong, H; Charatcharoenwitthaya, N; Pongchaiyakul, C; Namwongphrom, S; Kitumnuaypong, T; Srikam, W; Dajpratham, P; Kuptniratsaikul, V; Jaisamrarn, U; Tachatraisak, K; Rojanasthien, S; Damrongwanich, P; Wajanavisit, W; Pongprapai, S; Ongphiphadhanakul, B; Taechakraichana, N
代谢
骨质疏松
发表日期：2016
文献求助 收藏